--2025/Q1-- / 8.566M--
--2024/Q4-- / 8.246M--
Nov 7, 20242024/Q36.974M / 8.983M--
Aug 13, 20242024/Q27.262M / 11.049M--
May 14, 20242024/Q125.377M / 18.881M--
CA Stock MarketDetailed Quotes
FRX Fennec Pharmaceuticals Inc
- 8.910
- +0.340+3.97%
15min DelayMarket Closed Dec 23 16:00 ET
244.42MMarket Cap-165.00P/E (TTM)
9.000High8.490Low3.40KVolume8.490Open8.570Pre Close30.07KTurnover15.20052wk High0.02%Turnover Ratio27.43MShares5.65052wk Low-0.054EPS TTM167.58MFloat Cap391.500Historical HighLossP/E (Static)18.81MShs Float0.270Historical Low-0.795EPS LYR5.95%Amplitude--Dividend TTM-33.00P/B1Lot Size--Div YieldTTM
Fennec Pharmaceuticals Inc Key Stats
Fennec Pharmaceuticals Inc Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 8.98M | 6.97M | -2.01M |
| Miss Est. | +37.87% | +7.05% | -22.36% |
| EPS | -0.09 | -0.21 | -0.12 |
| Miss Est. | -28.61% | -200.00% | -133.59% |
Fennec Pharmaceuticals Inc Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Fennec Pharmaceuticals Inc Earnings Reports
Read more
Heat List
CA
Overall
Symbol
Price
% Chg
No Data